• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在自动中空纤维灌注生物反应器中大规模扩增悬浮细胞。

Large-Scale Expansion of Suspension Cells in an Automated Hollow-Fiber Perfusion Bioreactor.

作者信息

Bräuchle Eric, Knaub Maria, Weigand Laura, Ehrend Elisabeth, Manns Patricia, Kremer Antje, Fabre Hugo, Bonig Halvard

机构信息

Institute for Transfusion Medicine and Immunohematology, German Red Cross Blood Service Baden-Württemberg-Hessen, 60528 Frankfurt, Germany.

Faculty of Biological Science, Goethe University, 60439 Frankfurt, Germany.

出版信息

Bioengineering (Basel). 2025 Jun 12;12(6):644. doi: 10.3390/bioengineering12060644.

DOI:10.3390/bioengineering12060644
PMID:40564461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189701/
Abstract

Bioreactors enable scalable cell cultivation by providing controlled environments for temperature, oxygen, and nutrient regulation, maintaining viability and enhancing expansion efficiency. Automated systems improve reproducibility and minimize contamination risks, making them ideal for high-density cultures. While fed-batch bioreactors dominate biologics production, continuous systems like perfusion cultures offer superior resource efficiency and productivity. The Quantum hollow-fiber perfusion bioreactor supports cell expansion via semi-permeable capillary membranes and a closed modular design, allowing continuous media exchange while retaining key molecules. We developed a multiple-harvest protocol for suspension cells in the Quantum system, yielding 2.5 × 10 MEL-745A cells within 29 days, with peak densities of 4 × 10 cells/mL-a 15-fold increase over static cultures. Viability averaged 91.3%, with biweekly harvests yielding 3.1 × 10 viable cells per harvest. Continuous media exchange required more basal media to maintain glucose and lactate levels but meaningfully less growth supplement than the 2D culture. Stable transgene expression suggested phenotypic stability. Automated processing reduced hands-on time by one-third, achieving target cell numbers 12 days earlier than 2D culture. Despite higher media use, total costs for the automated were lower compared to the manual process. Quantum enables high-density suspension cell expansion with cost advantages over conventional methods.

摘要

生物反应器通过提供温度、氧气和营养调节的可控环境,实现可扩展的细胞培养,维持细胞活力并提高扩增效率。自动化系统提高了重现性并将污染风险降至最低,使其成为高密度培养的理想选择。虽然补料分批生物反应器在生物制品生产中占主导地位,但像灌注培养这样的连续系统具有更高的资源效率和生产率。量子中空纤维灌注生物反应器通过半透性毛细管膜和封闭式模块化设计支持细胞扩增,允许连续更换培养基,同时保留关键分子。我们为量子系统中的悬浮细胞开发了一种多次收获方案,在29天内产生了2.5×10个MEL-745A细胞,峰值密度为4×10个细胞/毫升,比静态培养增加了15倍。活力平均为91.3%,每两周收获一次,每次收获可产生3.1×10个活细胞。连续更换培养基需要更多的基础培养基来维持葡萄糖和乳酸水平,但与二维培养相比,生长补充剂的用量明显减少。稳定的转基因表达表明表型稳定。自动化处理将人工操作时间减少了三分之一,比二维培养提前12天达到目标细胞数量。尽管培养基用量较高,但与手动操作相比,自动化操作的总成本更低。量子系统能够实现高密度悬浮细胞扩增,与传统方法相比具有成本优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571e/12189701/b11503f12960/bioengineering-12-00644-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571e/12189701/0916c74fc1e4/bioengineering-12-00644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571e/12189701/b11503f12960/bioengineering-12-00644-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571e/12189701/0916c74fc1e4/bioengineering-12-00644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/571e/12189701/b11503f12960/bioengineering-12-00644-g002.jpg

相似文献

1
Large-Scale Expansion of Suspension Cells in an Automated Hollow-Fiber Perfusion Bioreactor.在自动中空纤维灌注生物反应器中大规模扩增悬浮细胞。
Bioengineering (Basel). 2025 Jun 12;12(6):644. doi: 10.3390/bioengineering12060644.
2
A 3-in-1 integrated automated platform for rapid CAR-T cell manufacturing: activation, transduction, and expansion in a hollow-fiber system.一种用于快速制造嵌合抗原受体T细胞(CAR-T)的三合一集成自动化平台:在中空纤维系统中进行激活、转导和扩增。
Cytotherapy. 2025 Aug;27(8):1001-1012. doi: 10.1016/j.jcyt.2025.05.006. Epub 2025 May 23.
3
Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors.优化和调整无血清培养基中的灌注补料,以增强搅拌罐生物反应器中CAR-T细胞的扩增。
Front Bioeng Biotechnol. 2025 Jun 2;13:1593895. doi: 10.3389/fbioe.2025.1593895. eCollection 2025.
4
Controlled activation modulates T-cell expansion and phenotype in stirred-tank bioreactors.可控激活可调节搅拌罐生物反应器中T细胞的扩增和表型。
Cytotherapy. 2025 Feb 14. doi: 10.1016/j.jcyt.2025.02.003.
5
Automated oxygen delivery for preterm infants with respiratory dysfunction.为呼吸功能障碍的早产儿提供自动输氧
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD013294. doi: 10.1002/14651858.CD013294.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
9
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.阿达木单抗、依那西普和英夫利昔单抗治疗成人类风湿关节炎有效性的系统评价及其成本效益的经济学评估。
Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. doi: 10.3310/hta10420.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

本文引用的文献

1
Rapid manufacture of low-seed CAR-T cells in a GMP-grade hollow-fiber bioreactor platform.在GMP级中空纤维生物反应器平台中快速制造低种子CAR-T细胞。
Cytotherapy. 2025 Mar;27(3):378-390. doi: 10.1016/j.jcyt.2024.11.003. Epub 2024 Nov 8.
2
Developing an ultra-intensified fed-batch cell culture process with greatly improved performance and productivity.开发一种超强化补料分批细胞培养工艺,具有显著提高的性能和生产力。
Biotechnol Bioeng. 2024 Feb;121(2):696-709. doi: 10.1002/bit.28605. Epub 2023 Nov 23.
3
An optimized HEK293T cell expansion protocol using a hollow-fiber bioreactor system.
一种使用中空纤维生物反应器系统的优化的HEK293T细胞扩增方案。
Biol Methods Protoc. 2023 Sep 13;8(1):bpad018. doi: 10.1093/biomethods/bpad018. eCollection 2023.
4
A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor.一种使用中空纤维生物反应器从骨髓间充质基质细胞大规模制造小细胞外囊泡的新方法。
Front Bioeng Biotechnol. 2023 Jan 24;11:1107055. doi: 10.3389/fbioe.2023.1107055. eCollection 2023.
5
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies.用于制造过继性细胞免疫疗法的生物反应器开发的最新进展
Bioengineering (Basel). 2022 Dec 15;9(12):808. doi: 10.3390/bioengineering9120808.
6
Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.T细胞、自然杀伤细胞、嵌合抗原受体T细胞和嵌合抗原受体自然杀伤细胞的代谢适应性对有效抗癌治疗的重要性:一个持续学习的过程,可优化基于T细胞、自然杀伤细胞和嵌合抗原受体的抗癌疗法。
Cancers (Basel). 2021 Dec 30;14(1):183. doi: 10.3390/cancers14010183.
7
Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing.从患者血浆中预先分析性去除药用抗 CD38 抗体,用于免疫血液学检测。
Blood. 2021 Sep 2;138(9):814-817. doi: 10.1182/blood.2021011396.
8
A Comparison of Automated Perfusion- and Manual Diffusion-Based Human Regulatory T Cell Expansion and Functionality Using a Soluble Activator Complex.使用可溶性激活复合物对基于自动化灌注和手动扩散的人调节性 T 细胞扩增和功能进行比较。
Cell Transplant. 2020 Jan-Dec;29:963689720923578. doi: 10.1177/0963689720923578.
9
A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.一种将分批补料平台工艺转换为半灌注模式的方案:与摇瓶相比,自动化小型生物反应器作为缩小规模模型的优势。
Biotechnol Prog. 2019 Mar;35(2):e2757. doi: 10.1002/btpr.2757. Epub 2018 Dec 19.
10
Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.用于临床应用的自动化生物反应器扩增间充质干细胞的特性及成本效益分析。
Transfusion. 2018 Oct;58(10):2374-2382. doi: 10.1111/trf.14805. Epub 2018 Sep 10.